An assessment of currently available i.v. Push medication delivery systems

A small panel of experts reviewed the current evidence and guidelines regarding the administration of i.v. push medications and the adherence of HCPs and health systems to those recommendations. The panel noted that significant variation from best-practice guidelines exists in current practice. Panel members believed that barriers to the use of more ideal i.v. push drug delivery systems should be addressed by healthcare organizations, and HCPs and healthcare lead-ers should become more familiar with the risks and benefits of such systems and strive to move practice toward optimal and safer administration practices. The opinions and recommendations of the expert panel are limited by the small number of panel members, and similar assessments by a larger group of stakeholders should be conducted to validate the views of the panel. Finally, panel members recognized that, as newer devices evolve, there is a need to reevaluate the systems periodically to ensure that appropriate modifications are made to the characteristics for an ideal RTA administration system.